Repeated dosing shifted age-related markers of brain inflammation in elderly volunteers toward levels seen in younger participants, demonstrating a downstream biological effect of TREM2 activation
Read more at prnewswire.comMuna Therapeutics Announces Positive Phase 1 Results Supporting Potential of Oral Small-Molecule TREM2 Modulator, MNA-001, in Alzheimer's Disease
Barchart·10/21/2026 06:30:00
語音播報
This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.